Invention Grant
- Patent Title: Bone marrow origin progenitor cell or endothelial progenitor cell in combination with DNMT1 gene therapy for vascular repair in metabolic disease
-
Application No.: US15044859Application Date: 2016-02-16
-
Publication No.: US09901639B2Publication Date: 2018-02-27
- Inventor: Hong Wang
- Applicant: Temple University—of the Commonwealth System of Higher Education
- Applicant Address: US PA Philadelphia
- Assignee: Temple University—of the Commonwealth System of Higher Education
- Current Assignee: Temple University—of the Commonwealth System of Higher Education
- Current Assignee Address: US PA Philadelphia
- Agency: Riverside Law LLP
- Main IPC: A01N63/00
- IPC: A01N63/00 ; A61K45/06 ; C12N5/071 ; A61K48/00 ; A61K35/28
Abstract:
The present invention provides an isolated population of bone marrow-derived endothelial progenitor cells (EPCs) and uses thereof for the treatment of vascular diseases.
Public/Granted literature
Information query
